Sofinnova Investments, Inc.

Q2 2024 13F Holdings Report, Stock Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park, CA
Holdings as of
30 Jun 2024
Value $
$1,586,926,722
Num holdings
72
Filing time
09 Aug 2024, 15:50:49 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included NTRA, VERA, ASND, NVO, and EW.
Previous filing
Q1 2024 - 14 Aug 2024
Next filing
Q3 2024 - 13 Nov 2024
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q2 compared to 2024 Q1 - Restatement by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 09 Aug 2024

*Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., Sofinnova BioEquities GP LLC, and Sofinnova Synergy GP LLC.